Home Data Calendar Blog

TCRT

Tables

    2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2022-12-31 2022-09-30 2021-12-31 2021-09-30 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31
Common Stock Value 0.000.000.020.020.240.240.240.220.220.220.160.140.140.140.140.140.140.130.100.080.080.080.080.080.080.080.070.070.07NA
Common Stock Par Or Stated Value Per Share 0.000.000.000.000.000.000.000.000.00NA0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00NA
dei: Entity Common Stock Shares Outstanding NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Weighted Average Number Of Diluted Shares Outstanding 1.601.6016.01NA240.05239.80NA215.10NA214.54NANANANANANANANANANANANANA78.6778.51NANA68.1067.23NA
Weighted Average Number Of Shares Outstanding Basic 1.601.6016.01NA240.05239.80NA215.10NA214.54NANANANANANANANANANANANANA78.6778.51NANA68.1067.23NA
Earnings Per Share Basic -0.70-0.71-0.11-2.09-0.04-0.04-0.04-0.04-0.06-0.111.29-0.13-0.12-0.15NANANANANANANANANA-0.23-0.30NANA-0.01-0.16NA
Earnings Per Share Diluted -0.70-0.71-0.11-2.09-0.04-0.04-0.04-0.04-0.06-0.111.29-0.13-0.12-0.15NANANANANANANANANA-0.23-0.30NANA-0.01-0.16NA

    2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2022-12-31 2022-09-30 2021-12-31 2021-09-30 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31
Revenue From Contract With Customer Excluding Assessed Tax 0.000.000.000.000.000.000.012.910.000.400.000.000.000.151.601.601.601.600.200.200.200.200.200.200.200.200.200.200.200.07
Revenue From Contract With Customer Including Assessed Tax 0.000.000.000.000.000.000.012.910.000.400.000.000.000.151.601.601.601.600.200.200.200.200.200.200.200.200.200.200.200.07
Revenues 0.000.000.000.000.000.000.012.910.000.400.000.000.000.151.601.601.601.600.200.200.200.200.200.200.200.200.200.200.200.07
Operating Expenses 1.151.171.747.958.667.998.5311.1811.0522.6912.7612.5712.3816.34NANANANANANANANANANANANANANANANA
Research And Development Expense 0.140.180.130.933.665.195.617.898.2214.528.208.267.4910.1811.1811.1110.8311.972.726.2514.7819.1134.9816.2118.2613.9812.6510.679.1224.64
General And Administrative Expense 1.010.991.622.433.583.042.923.282.108.174.564.314.896.163.853.573.783.604.203.073.724.674.065.714.904.853.973.743.923.35
Operating Income Loss -1.15-1.17-1.74-7.95-8.66-7.98-8.52-8.26-11.05-22.30-12.76-12.57-12.38-16.20-13.44-13.08-13.01-13.96-6.72-9.12-18.30-23.58-38.84-21.73-22.97-18.63-16.42-14.21-12.85-27.93
Net Income Loss -1.13-1.13-1.68-7.84-8.48-8.77-9.16-8.85-11.79-22.73194.54-12.59-12.03-16.02-18.27-12.70-12.86-15.49-8.90-16.71-18.69-12.80-30.23-17.82-23.61-24.47-13.24-0.80-10.72-39.01

    2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2022-12-31 2022-09-30 2021-12-31 2021-09-30 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31
Assets 3.554.686.048.2619.4427.9364.9467.3494.86113.7695.0566.8076.3887.46105.61116.56126.8194.4971.7529.4845.6063.3583.40105.64122.38140.87108.11122.28132.82NA
Liabilities 0.830.911.241.965.546.2826.3835.2336.8145.059.4962.7961.1961.5758.4257.2956.8559.9522.3725.8526.2725.4534.9646.6146.7443.1736.5038.1648.69NA
Liabilities And Stockholders Equity 3.554.686.048.2619.4427.9364.9467.3494.86113.7695.0566.8076.3887.46105.61116.56126.8194.4971.7529.4845.6063.3583.40105.64122.38140.87108.11122.28132.82NA
Stockholders Equity 2.723.774.806.3113.9021.6538.5532.1158.0668.7185.56-156.41-139.24-123.15-96.81-79.80-64.27-94.9049.383.6319.3337.8948.4559.0375.6497.7071.6184.1184.13NA

    2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2022-12-31 2022-09-30 2021-12-31 2021-09-30 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31
Assets Current 3.554.686.048.2612.8718.7853.8055.5178.8396.5584.2847.1652.9972.1190.78114.89125.1392.7570.3027.2743.0360.5680.28102.58119.44138.81106.11120.42131.30NA
Cash And Cash Equivalents At Carrying Value 1.682.464.146.0611.9418.3239.0637.8176.0591.7261.7331.7340.4051.1170.9584.4197.1966.4568.2023.6338.9355.6673.3195.33110.39128.01104.71118.93130.28124.04
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1.682.464.146.0611.9418.3253.0051.7476.0591.7261.7332.1240.7951.5071.3384.7997.5866.83NANANANANANANANANANANANA
Prepaid Expense And Other Assets Current 1.872.211.892.200.930.460.800.851.673.3220.6914.4111.9320.9919.8230.4727.8926.241.953.194.074.836.917.249.0510.801.311.411.02NA

    2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2022-12-31 2022-09-30 2021-12-31 2021-09-30 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31
Liabilities Current 0.830.911.241.964.685.0524.1732.8716.0428.179.4860.189.3110.0620.8618.1915.9917.467.7913.3621.0020.3618.8621.7417.7814.3313.3611.778.69NA
Accounts Payable Current 0.460.360.600.621.301.481.391.981.371.460.711.270.590.614.421.520.080.230.420.891.170.981.514.251.471.981.732.161.78NA
Accrued Liabilities Current 0.370.540.641.343.073.235.457.676.0813.968.769.388.668.889.9110.119.3510.696.3611.5718.9718.5216.5216.6815.5011.5310.828.796.08NA

    2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2022-12-31 2022-09-30 2021-12-31 2021-09-30 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31
Stockholders Equity 2.723.774.806.3113.9021.6538.5532.1158.0668.7185.56-156.41-139.24-123.15-96.81-79.80-64.27-94.9049.383.6319.3337.8948.4559.0375.6497.7071.6184.1184.13NA
Common Stock Value 0.000.000.020.020.240.240.240.220.220.220.160.140.140.140.140.140.140.130.100.080.080.080.080.080.080.080.070.070.07NA
Additional Paid In Capital Common Stock 922.43922.35922.23922.06921.58920.86918.94903.37900.69899.55651.73604.65609.25613.30615.49619.23622.05578.57386.51331.82330.74327.50325.18305.54304.22302.60246.52244.67243.81NA
Retained Earnings Accumulated Deficit -919.70-918.58-917.45-915.77-907.92-899.45-880.63-871.47-842.85-831.06-566.33-761.21-748.62-736.59-712.44-699.17-686.47-673.61-340.83NANANANANANANANANANANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.080.100.170.250.730.910.880.810.922.370.681.481.713.662.292.082.062.021.020.810.131.541.401.191.081.210.860.59NANA

    2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2022-12-31 2022-09-30 2021-12-31 2021-09-30 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31
Net Cash Provided By Used In Operating Activities -0.78-1.68-1.92-7.38-6.37-7.00-7.13-6.14-15.13-9.58-11.82-8.51-10.17-18.96-12.16-12.71NANA-9.04-15.50-16.72-18.24-21.50-14.71-16.77-25.86-13.75-11.10-5.82-8.17

    2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2022-12-31 2022-09-30 2021-12-31 2021-09-30 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31
Net Cash Provided By Used In Operating Activities -0.78-1.68-1.92-7.38-6.37-7.00-7.13-6.14-15.13-9.58-11.82-8.51-10.17-18.96-12.16-12.71NANA-9.04-15.50-16.72-18.24-21.50-14.71-16.77-25.86-13.75-11.10-5.82-8.17
Net Income Loss -1.13-1.13-1.68-7.84-8.48-8.77-9.16-8.85-11.79-22.73194.54-12.59-12.03-16.02-18.27-12.70-12.86-15.49-8.90-16.71-18.69-12.80-30.23-17.82-23.61-24.47-13.24-0.80-10.72-39.01
Increase Decrease In Accounts Payable 0.09-0.23-0.02-0.68-0.180.20-0.641.51-0.230.48-0.560.68-0.02-3.812.891.44-0.140.07-0.47-0.270.18-0.53-2.742.78-0.520.26-0.430.38-0.070.82
Share Based Compensation 0.080.100.170.250.730.910.880.810.922.370.681.481.713.662.292.082.062.021.020.810.131.541.401.191.081.210.860.590.610.70

    2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2022-12-31 2022-09-30 2021-12-31 2021-09-30 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31
Revenues 0.000.000.000.000.000.000.012.910.000.400.000.000.000.151.601.601.601.600.200.200.200.200.200.200.200.200.200.200.200.07
Revenue From Contract With Customer Excluding Assessed Tax 0.000.000.000.000.000.000.012.910.000.400.000.000.000.151.601.601.601.600.200.200.200.200.200.200.200.200.200.200.200.07
Royalty, Collaboration Agreement With Solasia Pharma Kk 0.000.010.000.000.000.00NANANANANANANANANANANANANANANANANANANANANANANANA
Collaboration Agreement With Solasia Pharma Kk 0.000.00NANA0.000.000.002.90NA0.40NANANANANANANANANANANANANANANANANANANANA
Revenue From Contract With Customer Including Assessed Tax 0.000.000.000.000.000.000.012.910.000.400.000.000.000.151.601.601.601.600.200.200.200.200.200.200.200.200.200.200.200.07

Plots across concepts


IncomeStatement
Operating Income Loss
Balance Sheet
Liabilities
Assets
Cash And Cash Equivalents At Carrying Value
Current Assets
Cash And Cash Equivalents At Carrying Value
Liabilities
Liabilities
Current Liabilities
Accrued Liabilities Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
Shares
Weighted Average Number Of Diluted Shares Outstanding
NonoperatingIncomeExpense
Nonoperating Income Expense

Line plots across dimensions of each concept